{"id":"NCT00670241","sponsor":"LEO Pharma","briefTitle":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris","officialTitle":"A Phase 3 Study Comparing a Gel Containing Calcipotriol 50 mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) With Tacalcitol Ointment (4 mcg/g) and Gel Vehicle, Used Once Daily in the Treatment of Psoriasis Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2009-02","completion":"2009-04","firstPosted":"2008-05-01","resultsPosted":"2011-03-08","lastUpdate":"2025-03-10"},"enrollment":458,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis Vulgaris"],"interventions":[{"type":"DRUG","name":"calcipotriol and betamethasone (LEO 80185 gel)","otherNames":[]},{"type":"DRUG","name":"LEO 80185 vehicle","otherNames":[]},{"type":"DRUG","name":"Tacalcitol ointment","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"PLACEBO_COMPARATOR"}],"summary":"This study will compare efficacy and safety of once daily treatment of calcipotriol plus betamethasone dipropionate gel (LEO 80185) with tacalcitol ointment and LEO 80185 vehicle alone in subjects with psoriasis vulgaris. Subjects will be treated for up to 8 weeks followed by an observation period of up to 8 weeks to investigate the occurence and the time to relapse and occurence of rebound after discontinuation of the investigational products. Only subjects with \"controlled disease\" will be considered for this observation phase of the study. \"Controlled disease\" is defined as \"Clear\" or \"Almost Clear\" severity category based on Investigator's global assessment (IGA).","primaryOutcome":{"measure":"Subjects With \"Controlled Disease\" (\"Clear\" or \"Almost Clear\" Disease) According to Investigator's Global Assessment of Disease Severity at Week 8","timeFrame":"Week 8","effectByArm":[{"arm":"Calcipotriol Plus Betamethasone Dipropionate Gel","deltaMin":73,"sd":null},{"arm":"Tacalcitol Ointment","deltaMin":33,"sd":null},{"arm":"Gel Vehicle","deltaMin":5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":21},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":["https://www.leopharmatrials.com/en"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":182},"commonTop":["Pruritus","Upper respiratory tract infection","Nasopharyngitis"]}}